Key facts
- This page summarizes Sagiv Shiv's Form 4 filing for Marpai, Inc. (MRAI).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Nov 2025, 06:49.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Purchase
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
On November 7, 2025, Marpai Inc. (the "Company") entered into a Securities Purchase Agreement for a private placement offering, in which the reporting person purchased 50,000 shares of common stock of the Company and common warrants to purchase up to 100,000 shares of common stock of the Company. The purchase price for each share of common stock and accompanying common warrant is $1.00. The common warrants have an exercise price of $1.00 per share, can be exercised immediately following the closing of the private placement offering and will be exercisable for three years following the date of issuance.